EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Molecular Mechanisms of Imatinib Treatment on Acute Lung Injury in Septic Mice Through Proteomic Technology

Xiao Wang, ZhiQing Zhou, DuanYang Li, BoYang Zhang, XiaoLong Zong, Xue Liang iD, ZhenYu Li iD

Journal of Immunology Research · 2025-01 · 2025 (1)

DOI: 10.1155/jimr/4526375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 09.06.2025. Verfasst von Xiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China. Hauptthemen laut MEDLINE: Imatinib Mesylate, Sepsis, Acute Lung Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute lung injury (ALI) is the most common complication of sepsis. Despite considerable progress in the treatment of sepsis, the effective treatment strategies are lacking. A previous study has shown that imatinib reduces the rate of acute pulmonary damage in septic mice; however, the molecular mechanism remains unclear. Therefore, the current study aimed to investigate the potential mechanism by which imatinib alleviates ALI in septic mice.

Methods

A septicemia model was established by intraperitoneal injection of lipopolysaccharide (LPS), followed by tail vein injection of imatinib in the treatment group. Enzyme‐linked immunosorbent assay (ELISA) was used to detect inflammatory factors, and hematoxylin staining was used to detect pathological injury to the lung tissue. Tandem mass tag (TMT) quantitative labeling technology was used for proteomic sequencing analysis. The main target protein was identified through bioinformatics, and its expression was confirmed using western blotting.

Results

We identified 128 differentially expressed proteins were associated with the protective effects of imatinib against septic lung injury. Functional enrichment analysis indicated that these proteins may be related to electron transfer, coagulation, and endothelial cell regulation in the oxidative respiratory chain. Enrichment of the nuclear factor‐kappa B (NF‐kB) signaling pathway, complement–coagulation cascade, and chemokine signaling pathway was also observed. Additionally, we found that the expression of CCAAT/enhancer‐binding protein delta (CEBPD) and pyruvate dehydrogenase kinase 4 (PDK4) increased in the sepsis group but decreased in the imatinib group.

Conclusion

Imatinib may reduce ALI in mice with sepsis by participating in oxidative respiratory and inflammatory responses, clotting response‐related signaling pathways, and downregulating CEBPD and PDK4 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imatinib MesylateSepsisAcute Lung InjuryAnimalsMiceProteomicsDisease Models, AnimalMaleSignal TransductionLipopolysaccharidesLungComputational BiologyProteome

Stichwörter der Autor:innen

acute lung injuryimatinibproteomicssepsis

Substanzen

Imatinib MesylateLipopolysaccharidesProteome

Autor:innen und Institutionen

  • Department of Emergency Medicine, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
  • Department of Clinical Laboratory, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.
  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University 300211, Tianjin, China.

ORCID-Profile: Xue Liang, ZhenYu Li

Zitieren

APA

Wang, X., Zhou, Z., Li, D., Zhang, B., Zong, X., Liang, X., & Li, Z. (2025). The Molecular Mechanisms of Imatinib Treatment on Acute Lung Injury in Septic Mice Through Proteomic Technology. Journal of Immunology Research, 2025(1). https://doi.org/10.1155/jimr/4526375

Vancouver

Wang X, Zhou Z, Li D, Zhang B, Zong X, Liang X, et al. The Molecular Mechanisms of Imatinib Treatment on Acute Lung Injury in Septic Mice Through Proteomic Technology. Journal of Immunology Research. 2025;2025(1). doi:10.1155/jimr/4526375

BibTeX
@article{Wang2025,
  author = {Wang, Xiao and Zhou, ZhiQing and Li, DuanYang and Zhang, BoYang and Zong, XiaoLong and Liang, Xue and Li, ZhenYu},
  title = {The Molecular Mechanisms of Imatinib Treatment on Acute Lung Injury in Septic Mice Through Proteomic Technology},
  journal = {Journal of Immunology Research},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/jimr/4526375}
}
Kostenlos starten →